Skip to content

Homeopathic treatment of facial paralysis

Individualized homoeopathic medicines in the treatment of Bellâ??s palsy in adults: A double-blind, randomized, placebo-controlled pilot trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077462
Enrollment
30
Registered
2024-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G510- Bells palsy

Interventions

Intervention1: Individualized homoeopathic medicines plus concomitant care: Administering indicated homeopathic medicines in centesimal potencies (CH) is the proposed intervention. Four cane sugar glo
the dosage and repetition depending upon the individual requirement of the cases. Patients will be instructed not to handle the globules or to refrain from smoking, eating, drinking, or brushing withi
duration-3 months minimum, physiotherapy, diet-vitamin C rich food should be recommended based on patientâ??s socioeconomic status and cultural backgrounds. Route of administration per oral. Duration
avoidance of cold wind exposure that may aggravates
duration-3 months minimum, physiotherapy, diet-vitamin C rich food should be recommended based on patientâ??s socioeconomic status and cultural backgrounds. Route of administration by oral. The therap

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from diagnosed Bellâ??s palsy (ICD10 code G51.0) on basis of clinical symptoms- a) Sudden unilateral (rarely bilateral) facial weakness, b) Loss of taste in tongue, c) Hyperacusis, d) Pain behind the ear. 2. Onset must be within 72 hours prior to enrolment. 3. Patients aged between 18 and 65 years. 4. Patients of either sex or transgender.

Exclusion criteria

Exclusion criteria: 1. Patients not providing written informed consent voluntarily. 2. Patients having 6th grade of idiopathic facial palsy (According to House-Brackmann facial nerve grading system), paroxysmal attack of facial pain, burning sensation in face, sharp neuralgic pain, long lasting pain, temporal bone pathologies etc. will be excluded from the study. 3. Patient having signs of upper motor neuron VII nerve palsy and cases of complete hemiplegia. 4. Patient facing diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life-threatening illness affecting quality of life or any organ failure. 5. Vulnerable groups of people: Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients. 6. Tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance, abuse and/or dependence (TAPS tool) 7. Self-reported state of immune-compromised. 8. Having recent or past oncological diagnosis. 9. Pregnant, puerperal or lactating mother. 10. Already under any other homoeopathic treatment for chronic disease for last 3 months. 11. Concurrently participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
Time to complete clinical recovery (days) compared between groupsTimepoint: On 2nd, 3rd, 5th, 7th, 14th, 21st, and 28th days of first month and then monthly up to three months

Secondary

MeasureTime frame
Sunnybrook facial grading systemTimepoint: Weekly for first month and then monthly up to three months.;House-Brackmann facial nerve grading systemTimepoint: Weekly for first month and then monthly up to three months;Measure Yourself Medical Outcome Profile version2 (MYMOP-2)Timepoint: Weekly for first month and then monthly up to three months.

Countries

India

Contacts

Public ContactMohan Giri

D N De Homoeopathic Medical College and Hospital

giri.drmohan@gmail.com9433904265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026